$0.693
-0.072 (-10.36%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MIST por análisis de gráficos similares
Alphio's MIST stock price prediction model matches the current Milestone Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.69 (-0.13%). The 1-week path is $0.66 (-4.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Milestone Pharmaceuticals Inc?
Milestone Pharmaceuticals Inc is a good buy right now due to its recent approval for etripamil in China, which triggered a $2 million milestone payment and opens up a significant market opportunity. The current price is $0.7268, and analysts project a price target of $3, suggesting a potential upside of approximately 313%. Additionally, the stock has shown a 5-day change of +12.79%, indicating positive momentum. However, the main risk is the company's substantial net losses, with a net income of -$28,614,000 in Q2 2026.
MIST cerró en $0.69 el Thursday, tras bajar -10.36%
Milestone Pharmaceuticals Inc (MIST) last closed at $0.6925, losing -10.36%. These facts feed the 1-day and 1-week MIST price prediction above.
Factores de la previsión
Los factores de la previsión de Milestone Pharmaceuticals Inc (MIST) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MIST, ordenadas por similitud.
Análisis de estacionalidad de MIST
Historically the probability of a positive November return for MIST is 50.00%. December offers the highest probability of a positive month at 65.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MIST
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.71 | $1.91 | $2.16 | +175.50% |
| Dec 2026 | $1.71 | $1.89 | $2.13 | +172.59% |
En 2026, se proyecta que Milestone Pharmaceuticals Inc (MIST) oscile entre $1.71 y $2.16.
Previsión mensual de Milestone Pharmaceuticals Inc para 2026
En Nov de 2026, se proyecta que Milestone Pharmaceuticals Inc promedie $1.91, con un mínimo de $1.71 y un máximo de $2.16.
En Dec de 2026, se proyecta que Milestone Pharmaceuticals Inc promedie $1.89, con un mínimo de $1.71 y un máximo de $2.13.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.